医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
ノート
薬剤師の介入によるソラフェニブの手足皮膚反応のリスクと服薬アドヒアランスの改善度の評価
鈴木 真也小田中 みのり船崎 秀樹西村 美子村永 愛戸田 繭子清水 怜光永 修一仲地 耕平池田 公史遠藤 一司和泉 啓司郎
著者情報
ジャーナル フリー

2011 年 37 巻 5 号 p. 317-321

詳細
抄録

In a retrospective study, pharmacists attended medical interviews and examinations conducted by a doctor and carried out follow-up interviews by telephone, to lessen the risk factors for hand-foot skin reactions (HFSR) caused by sorafenib in advanced hepatocellular carcinoma patients and improve treatment adherence for the drug. The study was conducted to assess the effectiveness of pharmacist intervention. The medical records and risk assessment sheets of 48 hepatocellular carcinoma patients who received sorafenib from June 2009 to May 2010 were reviewed.
There were 45 male and 3 female patients, with a median age of 70.5 (range 37-83) yrs. The Eastern Cooperative Oncology Group performance status was 0, 1 and 2 in 37, 10 and 1 patients, respectively. The incidence of HFSR was 73%(35/48), and the maximum grade of HFSR was 0, 1, 2 and 3 in 13, 7, 23 and 5 patients, respectively. The mean number of risk factors for HFSR was significantly reduced after pharmacist intervention as compared with that before (3.5 ± 2.1 vs. 1.4 ± 1.3, p<0.001). Non-adherence to sorafenib was observed in 17 patients (35%), but treatment adherence improved for all of these patients after pharmacist intervention.
Therefore, pharmacist intervention mitigated risk factors for HFSR and resolved the problem of non-adherence to treatment in patients with advanced hepatocellular carcinoma.

著者関連情報
© 2011 日本医療薬学会
前の記事 次の記事
feedback
Top